Alcamí J - Search Results

1

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.

Coiras M, López-Huertas MR, Pérez-Olmeda M, Alcamí J. Coiras M, et al. Among authors: alcami j. Nat Rev Microbiol. 2009 Nov;7(11):798-812. doi: 10.1038/nrmicro2223. Nat Rev Microbiol. 2009. PMID: 19834480 Review.

2

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

Bermejo M, Sánchez-Palomino S, Usán L, Alcamí J. Bermejo M, et al. Among authors: alcami j. J Med Virol. 2004 Aug;73(4):502-7. doi: 10.1002/jmv.20118. J Med Virol. 2004. PMID: 15221892

3

[Advances in the immunopathology of HIV infection].

Alcamí J. Alcamí J. Enferm Infecc Microbiol Clin. 2004 Oct;22(8):486-96. doi: 10.1016/s0213-005x(04)73144-4. Enferm Infecc Microbiol Clin. 2004. PMID: 15482691 Review. Spanish.

4

Current situation in the development of a preventive HIV vaccine.

Alcamí J, Joseph Munné J, Muñoz-Fernández MA, Esteban M. Alcamí J, et al. Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:5-24. doi: 10.1016/S0213-005X(05)75156-9. Enferm Infecc Microbiol Clin. 2005. PMID: 16373000 Free PMC article. Review. English, Spanish.

5

Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression.

Coiras M, Camafeita E, Ureña T, López JA, Caballero F, Fernández B, López-Huertas MR, Pérez-Olmeda M, Alcamí J. Coiras M, et al. Among authors: alcami j. Proteomics. 2006 Apr;6 Suppl 1:S63-73. doi: 10.1002/pmic.200500437. Proteomics. 2006. PMID: 16526095

6

A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.

Garcia-Perez J, Sanchez-Palomino S, Perez-Olmeda M, Fernandez B, Alcami J. Garcia-Perez J, et al. Among authors: alcami j. J Med Virol. 2007 Feb;79(2):127-37. doi: 10.1002/jmv.20770. J Med Virol. 2007. PMID: 17177310

7

Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.

Coiras M, López-Huertas MR, Rullas J, Mittelbrunn M, Alcamí J. Coiras M, et al. Among authors: alcami j. Retrovirology. 2007 Aug 8;4:56. doi: 10.1186/1742-4690-4-56. Retrovirology. 2007. PMID: 17686171 Free PMC article.

8

A new strategy based on recombinant viruses for assessing the replication capacity of HIV-1.

Garcia-Perez J, Perez-Olmeda M, Sanchez-Palomino S, Perez-Romero P, Alcami J. Garcia-Perez J, et al. Among authors: alcami j. HIV Med. 2008 Mar;9(3):160-71. doi: 10.1111/j.1468-1293.2007.00540.x. Epub 2008 Jan 21. HIV Med. 2008. PMID: 18217999 Free article.

9

Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents.

Coiras M, Camafeita E, López-Huertas MR, Calvo E, López JA, Alcamí J. Coiras M, et al. Among authors: alcami j. Proteomics. 2008 Feb;8(4):852-73. doi: 10.1002/pmic.200700664. Proteomics. 2008. PMID: 18297655 Free PMC article. Review.

10

Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes.

Coiras M, López-Huertas MR, Mateos E, Alcamí J. Coiras M, et al. Among authors: alcami j. Retrovirology. 2008 Dec 1;5:109. doi: 10.1186/1742-4690-5-109. Retrovirology. 2008. PMID: 19046417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page